FDA approves Pfizer maternal RSV vaccine for infants

Pfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.